Functional Outcomes After ‘SHURUI’ Single‐Port Robot‐Assisted Pyeloplasty for Uretero Pelvic Junction Obstruction: Single‐Centre Experience

Abstract

BACKGROUND: To explore the preliminary safety and efficacy of domestic single-port robot-assisted pyeloplasty in ureteropelvic junction obstruction. METHODS: Data from patients undergoing single-port robotic-assisted pyeloplasty (November 2023-May 2024) using the 'SHURUI' SP system through a single-site approach were reviewed. Details included patient demographics, intraoperative and postoperative data, and surgical outcomes. RESULTS: The study included 20 patients, ages 13-39, with a male-to-female ratio of 4:1. CLINICAL PRESENTATIONS: abdominal pain (7cases), infection (2cases), and asymptomatic (11cases). All surgeries were successful, with an average operation time of 147(IQR, 125-175) minutes, blood loss of 35(IQR, 30-60) mL, and a hospital stay of 5(IQR, 3-6)days. The ureteral stent was removed 6-8 weeks post-surgery, with a subsequent CT scan at 4 months showing 100% success based on pain and obstruction resolution. CONCLUSION: The 'SHURUI' single-port robotic-assisted pyeloplasty is a safe and feasible treatment for UPJO in both adults and paediatric patients.